SMARCB1-deficient and SMARCA4-deficient malignant brain tumors with complex copy number alterations and TP53 mutations may represent the first clinical manifestation of Li-Fraumeni syndrome - Hasselblatt, Martin; Thomas, Christian; Federico, Aniello; Nemes, Karolina; Johann, Pascal-David; Bison, Brigitte; Bens, Susanne; Dahlum, Sonja; Kordes, Uwe; Redlich, Antje Karen; Lessel, Lienhard; Pajtler, Kristian Wilfried; et al. (The American journal of surgical pathology, 2022)